PRRT2 and retinal disorder: Levetiracetam for treatment of retinopathy (Mohammad et al., 2019) as well as for the repair of convulsant- induced cognitive impairment (Wang et al., 2019a) directly signals through the PKC/GAP-43 signaling pathway.